|
|
8David H Martin
![]() Summary for 2004 [at-glance overview of David H Martin work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author David H Martin. According to available data, in 2004 David H Martin published at least 8 articles. This work was completed in collaboration with several authors including Quinn, Thomas C and Hook, Edward W. Many other authors have collaborated with David H Martin as well. At least 28 different grants are awarded to David H Martin to support this work. All time total of the grant awards on file exceeds $40,831,714.
David H Martin is a key opinion leader in the specific area of Chlamydia trachomatis. This author's rank is 3 when compared to all other authors using the same keyword. Analysis of the article abstracts and the titles suggests that David H Martin professional interests are focused around "infected-patient gold standard", "infected patient standard" and "define infected-patient gold". These might also be referred to as "infected-patient gold", "chlamydia trachomatis" or "gold standard". Statistical analysis shows that David H Martin's writing is likely to contains terms "chlamydia", "standard", "sensitivity", "specimens", "results" and "vaginae".
Unfortunately, there is not enough information to establish David H Martin affiliation. Luckily, several email addresses are on file. Images [images we found on the Internet for David H Martin]loading...
Do you know David H Martin who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to David H Martin]Year 2004 Charts [David H Martin frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of David H Martin publication and funding history for the range of years]Emails (6) [email addresses extracted from David H Martin affiliations]hidden to prevent spam, click here to reveal David H Martin Coauthors (23) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (7) [condensed summary of the David H Martin affiliations, the leading number and the color conveys importance]- 2Department Dept of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
1Department of Medicine, Section of Infectious Diseases, Health Sciences Center, Louisiana State University, New Orleans, Louisiana 70112, USA. 1Section of Infectious Diseases, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. 1Department of Medicine, Section of Infectious Diseases, School of Medicine in New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. 1University of California, San Francisco, California 94110, USA. 1Department of Microbiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. 1Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA.
Key Opinion Leader In [David H Martin is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 3Chlamydia trachomatis | 6Chlamydia Infections
Keywords (32) [keywords assigned to David H Martin articles by PubMed, the leading number and the color conveys importance]- 8Humans | 6Female | 4Chlamydia trachomatis | 4Chlamydia Infections | 4Adult | 4Male | 3Adolescent | 3Middle Aged | 2United States | 2Gonorrhea | 2RNA, Ribosomal, 16S | 2Vaginosis, Bacterial | 2Actinobacteria | 2Vagina | 2Prevalence | 2Molecular Sequence Data | 2Polymerase Chain Reaction | 2Sequence Analysis, DNA | 1Phylogeny | 1Base Sequence | 1Adolescent Health Services | 1Urban Health | 1Sensitivity and Specificity | 1Genetic Variation | 1Urban Population | 1Age Distribution | 1Male Urogenital Diseases | 1Genotype | 1Sex Distribution | 1Body Fluids | 1Species Specificity | 1Clinical Trials as Topic
David H Martin Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; David H Martin might be a good expert witness on these terms]- 16chlamydia | 13standard | 11sensitivity | 11specimens | 10results | 9vaginae | 9trachomatis | 9gold | 9infected-patient | 8clinical | 8ac2 | 8rrna | 8different | 8study | 8among | 7infected | 7patient | 7urine | 7patients | 7ct | 6studies | 6bacterial | 6gene | 6fcu | 6pcr | 5atopobium | 5school | 5vaginosis | 5data | 5ng | 5lcr | 5define
- 9infected-patient gold | 8chlamydia trachomatis | 7gold standard | 6infected patient | 6patient standard | 6chlamydia gonorrhea | 5atopobium vaginae | 5bacterial vaginosis | 4define infected-patient | 4diagnostic tests | 4symptomatic infection | 3vaginal flora | 316s rrna | 3rrna gene | 3aptima combo | 3operon variable | 3mycoplasma genitalium | 3fcu specimens | 3tandem repeats | 3chain reaction | 3repeats lipoprotein | 3lipoprotein gene | 3genitalium strains | 3rrna operon | 3standard reduces | 3metronidazole resistant | 3strains clinical | 3gonorrhea co-occurrence | 3variable numbers | 3endocervical swabs | 3acid amplification | 3clinical specimens
- 7infected-patient gold standard | 6infected patient standard | 4define infected-patient gold | 316s rrna gene | 3variable numbers tandem | 3numbers tandem repeats | 3single-nucleotide polymorphisms rrna | 3genitalium strains clinical | 3gen-probe aptima combo | 3mycoplasma genitalium strains | 3chlamydia gonorrhea co-occurrence | 3polymorphisms rrna operon | 3repeats lipoprotein gene | 3operon variable numbers | 3tandem repeats lipoprotein | 3rrna operon variable | 3acid amplification tests | 3patient standard reduces | 3standard reduces sensitivity | 3among mycoplasma genitalium | 3strains clinical specimens | 3nucleic acid amplification | 2standard clinical trials | 2evaluations sensitivity gen-probe | 2combo assay endocervical | 2ligase chain reaction | 2species-directed 16s rrna | 2swabs chlamydia trachomatis | 2clinical trials diagnostic | 2trachomatis neisseria gonorrhoeae | 2gonorrhea co-occurrence school | 2gene pcr primers
Reader's Comments (0) [comments posted by readers of David H Martin profile]Funding (28) [selected NIH grants to David H Martin and the award amounts for recent years]- NMDA RECEPTORS AFTER PRENATAL ETHANOL EXPOSURE (MARTIN, DAVID - 1990)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- CROSS-CULTURAL COMMUNITY HEALTH STUDIES (MARTIN, DAVID - 1974)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- ANALYSIS OF HOMOLOGOUS RECOMBINATION IN HSV 1 (MARTIN, DAVID - 1995)
| Grant # | Award Year | Award Amount, USD | | 1F32AI009143-01A1 | 1995 | $23,700 | | 5F32AI009143-02 | 1996 | $28,600 | | 5F32AI009143-03 | 1997 | $29,900 | | Total up to 2004 | $82,200 |
- MODEL FOR NUCLEOSIDE PHOSPHORYLASE DEFICIENCY (MARTIN, DAVID - 1981)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- IMMUNOGENICITY OF HSV AMPLICONS IN RHESUS MACAQUES (MARTIN, DAVID - 2003)
| Grant # | Award Year | Award Amount, USD | | 1R21AI055369-01 | 2003 | $252,000 | | 5R21AI055369-02 | 2004 | $251,250 | | Total up to 2004 | $503,250 |
- GULF SOUTH STI/TOPICAL MICROBICIDE COOPERATIVE RES CENT (MARTIN, DAVID - 2004)
| Grant # | Award Year | Award Amount, USD | | 1U19AI061972-01 | 2004 | $1,778,604 | | Total up to 2004 | $1,778,604 |
- HOST RANGE DIVERSITY OF BACTERIOPHAGE FOR Y. PESTIS (MARTIN, DAVID - 2006)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- STUDIES IN GENETIC REGULATION OF PURINE METABOLISM (MARTIN, DAVID - 1978)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- MECHANISMS OF DENDRITIC CELL RESPONSES TO ENDOGENOUS DNA (MARTIN, DAVID - 2005)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- A NEW ABSORBABLE ANTIMICROBIAL BONE GRAFT SUBSTITUTE (MARTIN, DAVID - 2005)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- GERMLINE EPIMUTATION OF HMLH1 AS A FACTOR IN HNPCC (MARTIN, DAVID - 2005)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- DIET, EPIGENETIC EVENTS, AND CANCER PREVENTION (MARTIN, DAVID - 2005)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- A NEW ABSORBABLE MESH FOR HERNIA REPAIR (MARTIN, DAVID - 2004)
| Grant # | Award Year | Award Amount, USD | | 1R43EB003644-01 | 2004 | $100,000 | | Total up to 2004 | $100,000 |
- AN ASSAY TO IDENTIFY AND CLASSIFY EPIMUTAGENS (MARTIN, DAVID - 2008)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- MEDICAL SCIENTIST (MARTIN, DAVID - 1978)
| Grant # | Award Year | Award Amount, USD | | 5T32GM007618-15 | 1992 | $608,049 | | 2T32GM007618-16 | 1993 | $702,520 | | 5T32GM007618-17 | 1994 | $769,611 | | 5T32GM007618-18 | 1995 | $650,563 | | 5T32GM007618-19 | 1996 | $758,386 | | 5T32GM007618-20 | 1997 | $822,667 | | 2T32GM007618-21 | 1998 | $837,509 | | 5T32GM007618-22 | 1999 | $857,392 | | 5T32GM007618-23 | 2000 | $999,383 | | 2T32GM007618-24 | 2001 | $992,076 | | 5T32GM007618-25 | 2002 | $1,094,257 | | 5T32GM007618-26 | 2003 | $1,162,750 | | 5T32GM007618-27 | 2004 | $1,193,142 | | Total up to 2004 | $11,448,305 |
- GENETIC REGULATION OF MAMMALIAN PURINE METABOLISM (MARTIN, DAVID - 1972)
| Grant # | Award Year | Award Amount, USD | | 1F31GM019527-01 | 1997 | $25,074 | | 5F31GM019527-02 | 1999 | $24,422 | | Total up to 2004 | $49,496 |
- BIOPOLYMER FIBER AS A BIOABSORBABLE MONOFILAMENT SUTURE (MARTIN, DAVID - 2002)
| Grant # | Award Year | Award Amount, USD | | 1R43GM064863-01 | 2002 | $99,313 | | 2R44GM064863-02 | 2004 | $398,996 | | Total up to 2004 | $498,309 |
- GLOBIN GENE REGULATION BY RC TRANSCRIPTION FACTOR GATA-1 (MARTIN, DAVID - 1992)
| Grant # | Award Year | Award Amount, USD | | 1R01HL048790-01 | 1992 | $181,172 | | 5R01HL048790-02 | 1993 | $180,995 | | 5R01HL048790-03 | 1994 | $231,814 | | 5R01HL048790-04 | 1995 | $239,570 | | 2R01HL048790-05 | 1996 | $239,321 | | 5R01HL048790-06 | 1997 | $223,229 | | 5R01HL048790-07 | 1998 | $255,497 | | 5R01HL048790-08 | 1999 | $286,382 | | Total up to 2004 | $1,837,980 |
- CONTROL OF GAMMA-AMINOBUTYRIC ACID METABOLISM (MARTIN, DAVID - 1975)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- TREATMENT OF PHYSIOLOGICAL IMPOTENCY (MARTIN, DAVID - 1976)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- CONTROL OF GAMMA-AMINOBUTYRIC ACID SYNTHESIS (MARTIN, DAVID - 1977)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- CONTROL OF GAMMA-AMINOBUTYRIC ACID SYNTHESIS (MARTIN, DAVID - 1980)
| Grant # | Award Year | Award Amount, USD | | 5R37MH035664-13 | 1992 | $136,385 | | 5R37MH035664-14 | 1993 | $153,611 | | 4R37MH035664-15 | 1994 | $154,788 | | 5R37MH035664-16 | 1995 | $161,241 | | 5R37MH035664-17 | 1996 | $167,419 | | 5R37MH035664-18 | 1997 | $174,115 | | 5R37MH035664-19 | 1998 | $181,079 | | Total up to 2004 | $1,128,638 |
- COGNITIVE DEFICIT AND SELF SCHEMA IN DEPRESSIVE SUBTYPES (MARTIN, DAVID - 1986)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- WORKING WITH HIV/AIDS: A MIXED MODALITY INTERVENTION (MARTIN, DAVID - 2001)
| Grant # | Award Year | Award Amount, USD | | 1R01MH062966-01A1 | 2001 | $618,632 | | 5R01MH062966-02 | 2002 | $627,993 | | 5R01MH062966-03 | 2003 | $604,539 | | 5R01MH062966-04 | 2004 | $574,245 | | Total up to 2004 | $2,425,409 |
- BIOMATERIALS FOR THE CENTRAL NERVOUS SYSTEM (Martin, David, UNIVERSITY OF MICHIGAN AT ANN ARBOR - 2001)
| Grant # | Award Year | Award Amount, USD | | N01NS012338-000 | 2001 | $973,394 | | N01NS012338-004 | 2003 | $519,810 | | Total up to 2004 | $1,493,204 |
- SODIUM-DEPENDENT HIGH AFFINITY TRANSPORT IN GLIA (MARTIN, DAVID - 1980)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- SURFACE MODIFICATION FOR BIOCOMPATIBILITY (MARTIN, DAVID - 1995)
| Grant # | Award Year | Award Amount, USD | | 1N01NS052322-000 | 1995 | $203,969 | | 5N01NS052322-001 | 1996 | $210,904 | | 5N01NS052322-002 | 1997 | $218,073 | | Total up to 2004 | $632,946 |
- ARTIFICIAL BREEDING OF CHIMPANZEES (MARTIN, DAVID - 1976)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
David H Martin Articles (8) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis. (2004) >> Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA. 2Ferris, Michael J, 2Masztal, Alicia, 8Martin, David H.Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections. (2004) >> Department of Medicine, Section of Infectious Diseases, Health Sciences Center, Louisiana State University, New Orleans, Louisiana 70112, USA. 3Schachter, Julius, 9Hook, Edward W, 14Quinn, Thomas C, 2Nsuami, Malanda, 2Ferrero, Dennis, 3Gaydos, Charlotte, 8Martin, David H.Single-nucleotide polymorphisms in the rRNA operon and variable numbers of tandem repeats in the lipoprotein gene among Mycoplasma genitalium strains from clinical specimens. (2004) >> Section of Infectious Diseases, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. 4Ma, Liang, 8Martin, David H.Chlamydia and gonorrhea co-occurrence in a high school population. (2004) >> Department of Medicine, Section of Infectious Diseases, School of Medicine in New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. 2Nsuami, Malanda, 1Brooks, Bridget N, 2Taylor, Stephanie N, 1Cammarata, Catherine L, 8Martin, David H.The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation. (2004) >> University of California, San Francisco, California 94110, USA. 1Moncada, Jeanne, 3Schachter, Julius, 9Hook, Edward W, 14Quinn, Thomas C, 2Ferrero, Dennis, 3Gaydos, Charlotte, 1Willis, Dean, 8Martin, David H, 1Weissfeld, Alice.An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. (2004) >> Department of Microbiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. 3Dunlap, Kathleen, 3Sturtevant, Joy, 6Fidel, Paul L, 1Barousse, Melissa, 3Quayle, Alison J, 1Ficarra, Mercedes, 1Espinosa, Terri, 8Martin, David H.Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. (2004) >> Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA. 3Stamm, Walter E, 12Johnson, Robert E, 1Millman, Kim, 6Bolan, Gail, 5Tavaré, Simon, 2Jones, Robert B, 2Hook, Edward W, 5Black, Carolyn M, 8Martin, David H, 5Dean, Deborah.Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. (2004) >> Dept of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA. 2Ferris, Michael J, 3Aldridge, Kenneth E, 6Fidel, Paul L, 6Fortenberry, J Dennis, 2Masztal, Alicia, 8Martin, David H.
Science Trivia (2) [Interactive math & science trivia questions]
|
|